(Q35862757)
Statements
Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials (English)
1 reference
T. P. Cooley
J. S. Lambert
G. L. Drusano
G. J. Yuen
G. Morse
M. Seidlin
H. A. Liebman
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference